Abstract
One of the major challenges of RNA-based therapeutics is the method for delivery of RNA molecules. In a recent article (Nat Commun 9(1):2359), we described a novel delivery platform for RNA-based drugs using red blood cell extracellular vesicles which can efficiently deliver both small and large RNAs to solid and liquid tumours. Our RBCEVs platform features exceptional merits over conventional RNA delivery methods in biosafety, biocompatibility, efficiency, accessibility, and cost effectiveness.
Original language | English |
---|---|
Pages (from-to) | 239-241 |
Number of pages | 3 |
Journal | Cell Stress |
Volume | 2 |
Issue number | 9 |
DOIs | |
Publication status | Published - Sept 2018 |
Externally published | Yes |
Keywords
- Cancer
- Extracellular vesicles
- Red blood cells
- RNA
- Therapeutics